WuXi Biologics Reports Remarkable 2022 Annual Results
- Wednesday, March 22, 2023, 7:12
- Environment
- Add a comment
Revenue Increased by 48.4% Y-o-Y to RMB15,268.7 Million Gross Profit Increased by 39.2% Y-o-Y to RMB6,724.0 Million Adjusted Net Profit Rose by 47.1% to RMB5,053.9 Million Non-COVID Revenue Achieved 63% Y-o-Y Growth, Strong Momentum Continues into 2023 and Beyond “R” in CRDMO Business…
About the Author
adminasapcorp has written 39540 stories on this site.